Table II.
Endometrial cancer (n = 118) | Non-cases (n = 9714) | HRa | 95% CI | |
---|---|---|---|---|
Race | ||||
White | 91 | 7376 | 1.00 | Referent |
African–American | 4 | 441 | 0.65 | 0.24–1.81 |
Other | 7 | 525 | 1.04 | 0.48–2.25 |
Unknown | 16 | 1372 | 0.83 | 0.49–1.42 |
Reproductive status at the first clinic visit | ||||
Gravid | 60 | 5589 | 1.00 | Referent |
Nulligravid | 58 | 4125 | 1.31 | 0.91–1.88 |
Reproductive status at follow-up | ||||
Gravid | 79 | 6897 | 1.00 | Referent |
Nulligravid | 23 | 1357 | 1.54 | 0.53–1.55 |
Unknown | 16 | 1460 | 0.90 | 0.96–2.44 |
Number of births at follow-up | ||||
≥3 | 9 | 998 | 1.00 | Referent |
2 | 16 | 1718 | 1.09 | 0.48–2.48 |
1 | 23 | 1465 | 1.77 | 0.82–3.84 |
0 | 35 | 2037 | 2.08 | 1.00–4.33 |
Unknown | 35 | 3496 | 1.09 | 0.52–2.26 |
Age at menarche | ||||
<12 | 30 | 1891 | 1.00 | Referent |
12 | 34 | 2643 | 0.82 | 0.50–1.33 |
13 | 30 | 2902 | 0.66 | 0.40–1.09 |
≥14 | 17 | 1999 | 0.51 | 0.28–0.93 |
Unknown | 7 | 279 | 1.68 | 0.73–3.89 |
Ever use of oral contraceptives | ||||
No | 14 | 915 | 1.00 | Referent |
Yes | 67 | 5862 | 0.77 | 0.43–1.37 |
Unknown | 37 | 2937 | 0.82 | 0.44–1.52 |
Ever use of menopausal hormones | ||||
No | 25 | 2046 | 1.00 | Referent |
Yes | 36 | 2605 | 1.19 | 0.71–1.99 |
Unknown | 57 | 5063 | 0.95 | 0.59–1.53 |
BMI at the first clinic visit (quartiles, kg/m2) | ||||
<23.0 | 47 | 4854 | 1.00 | Referent |
23.0–24.9 | 10 | 1078 | 0.99 | 0.50–1.97 |
25.0–29.9 | 11 | 1010 | 1.15 | 0.59–2.23 |
≥30.0 | 21 | 451 | 5.18 | 3.06–8.75 |
Unknown | 29 | 2321 | 1.55 | 0.92–2.62 |
BMI at age 40 (quartiles, kg/m2) | ||||
<23.0 | 21 | 2207 | 1.00 | Referent |
23.0–24.9 | 12 | 1080 | 1.20 | 0.59–2.44 |
25.0–29.9 | 17 | 916 | 2.00 | 1.05–3.81 |
≥30.0 | 11 | 422 | 2.90 | 1.39–6.04 |
Unknown | 57 | 5089 | 1.20 | 0.72–2.00 |
Cause of infertilityb | ||||
Endometriosis | 22 | 2181 | 0.90 | 0.54–1.49 |
Anovulation | 35 | 2723 | 1.15 | 0.77–1.72 |
Tubal disease/pelvic adhesions | 39 | 3457 | 0.98 | 0.65–1.47 |
Male factor | 39 | 2176 | 1.63 | 1.07–2.50 |
Cervical disorder | 7 | 605 | 0.87 | 0.39–1.93 |
Uterine disorder | 10 | 1036 | 0.84 | 0.43–1.65 |
aHRs adjusted for study site and calendar year of the first infertility evaluation.
bRisks are relative to women with no evidence of the condition, taking into account the adequacy of the evaluation. Conditions are not mutually exclusive, i.e. women could be classified as having more than one cause of infertility.